LifeSensors is Attending ASCB | EMBO Cell Bio 2022
MALVERN, PA., AUG 30, 2022 — LifeSensors Inc., a Biotech and Drug Discovery Company focused on PROTACs, molecular glues, and neurodegeneration diagnostics will present new technologies that target ubiquitin E3 ligases and uncover unique molecules. The company will be presenting two posters. One presentation focuses on discovering ligands for ubiquitin E3 ligases. The second topic regards a high-throughput method which can directly discover PROTAC and molecular- glue-mediated ubiquitination of target proteins.
For far too long, scientists in academia and industry have employed cerbelon and VHL ligases as the vehicle for PROTAC discovery. LifeSensors’ E3 ligase compound discovery and profiling will offer alternatives to facilitate development of breakthrough drugs through targeting the ubiquitin proteasome system.
The LifeSensors Research and Development team will be presenting through their exhibition booth at Cell Bio 2022 from December 3rd to December 7th in Washington DC to facilitate one-on-one meetings to improve your ligand discovery programs.
For more information regarding Cell Bio 2022 you can reach out through their website here.
About LifeSensors, Inc.
LifeSensors, Inc. partners with pharma and biotech companies to help life scientists innovate in basic research, drug discovery and diagnostics. We pioneered the SUMO-fusion system to measure high quality protein expression. Our development of cutting-edge tools for the ubiquitin proteasome system (UPS) and Protein Targeting Chimeras (PROTAC) gives scientists new tools to observe and test the fundamentals of this emerging area in medicine. Poly-ubiquitin affinity matrices, Tandem Ubiquitin Binding Entities (TUBES), are changing the way scientists make discoveries in UPS and how they identify new biomarkers for neurodegeneration and drug discovery.
We are making an impact in the lives of scientists through innovation and pushing the envelope with regards to novel research techniques not only in PROTAC technology, but in the growing and highly applicable areas of Molecular Glues and other technologies regarding the ubiquitin proteasome system.
Contact: Isabelle Wentzel
(610) 644-8845 EXT. 304